USANA Health Sciences, Inc. (NYSE:USNA) major shareholder Global Ltd Gull sold 82,407 shares of the company’s stock in a transaction dated Thursday, March 8th. The stock was sold at an average price of $81.24, for a total value of $6,694,744.68. Following the completion of the sale, the insider now directly owns 11,439,646 shares of the company’s stock, valued at approximately $929,356,841.04. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Major shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

Global Ltd Gull also recently made the following trade(s):

How to Become a New Pot Stock Millionaire
  • On Monday, March 12th, Global Ltd Gull sold 67,464 shares of USANA Health Sciences stock. The stock was sold at an average price of $80.84, for a total value of $5,453,789.76.
  • On Thursday, March 1st, Global Ltd Gull sold 11,950 shares of USANA Health Sciences stock. The stock was sold at an average price of $75.77, for a total value of $905,451.50.
  • On Wednesday, February 14th, Global Ltd Gull sold 34,205 shares of USANA Health Sciences stock. The stock was sold at an average price of $75.70, for a total value of $2,589,318.50.
  • On Monday, February 12th, Global Ltd Gull sold 10,287 shares of USANA Health Sciences stock. The stock was sold at an average price of $75.39, for a total value of $775,536.93.
  • On Friday, February 9th, Global Ltd Gull sold 1,984 shares of USANA Health Sciences stock. The stock was sold at an average price of $74.78, for a total value of $148,363.52.
  • On Monday, February 5th, Global Ltd Gull sold 8,344 shares of USANA Health Sciences stock. The stock was sold at an average price of $72.28, for a total value of $603,104.32.
  • On Friday, February 2nd, Global Ltd Gull sold 2,753 shares of USANA Health Sciences stock. The stock was sold at an average price of $74.24, for a total value of $204,382.72.

USANA Health Sciences, Inc. (NYSE:USNA) opened at $81.90 on Thursday. USANA Health Sciences, Inc. has a one year low of $52.55 and a one year high of $82.40. The company has a market capitalization of $1,970.00, a PE ratio of 21.78 and a beta of 0.94.

USANA Health Sciences (NYSE:USNA) last released its quarterly earnings results on Tuesday, February 6th. The company reported $1.11 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.00 by $0.11. USANA Health Sciences had a return on equity of 27.08% and a net margin of 5.97%. The business had revenue of $273.11 million for the quarter, compared to analysts’ expectations of $258.67 million. During the same quarter in the previous year, the firm posted $0.87 earnings per share. The company’s revenue was up 8.0% compared to the same quarter last year. research analysts expect that USANA Health Sciences, Inc. will post 4.25 earnings per share for the current fiscal year.

Several large investors have recently added to or reduced their stakes in USNA. Parametric Portfolio Associates LLC lifted its stake in shares of USANA Health Sciences by 9.8% in the second quarter. Parametric Portfolio Associates LLC now owns 26,576 shares of the company’s stock worth $1,704,000 after acquiring an additional 2,361 shares in the last quarter. Voya Investment Management LLC lifted its stake in shares of USANA Health Sciences by 13.4% in the second quarter. Voya Investment Management LLC now owns 5,712 shares of the company’s stock worth $366,000 after acquiring an additional 676 shares in the last quarter. State Street Corp lifted its stake in shares of USANA Health Sciences by 7.4% in the second quarter. State Street Corp now owns 208,993 shares of the company’s stock worth $13,401,000 after acquiring an additional 14,353 shares in the last quarter. The Manufacturers Life Insurance Company lifted its stake in shares of USANA Health Sciences by 7.2% in the second quarter. The Manufacturers Life Insurance Company now owns 9,137 shares of the company’s stock worth $586,000 after acquiring an additional 616 shares in the last quarter. Finally, California State Teachers Retirement System lifted its stake in shares of USANA Health Sciences by 0.5% in the second quarter. California State Teachers Retirement System now owns 20,582 shares of the company’s stock worth $1,319,000 after acquiring an additional 100 shares in the last quarter. Institutional investors and hedge funds own 48.25% of the company’s stock.

Several equities research analysts have recently weighed in on the company. TheStreet downgraded USANA Health Sciences from a “b+” rating to a “c+” rating in a research report on Tuesday, February 6th. Pivotal Research upped their target price on USANA Health Sciences from $80.00 to $95.00 and gave the stock a “buy” rating in a research report on Wednesday, February 7th. Finally, Sidoti cut USANA Health Sciences from a “buy” rating to a “neutral” rating in a research note on Wednesday, January 24th.

WARNING: This report was first reported by Daily Political and is owned by of Daily Political. If you are accessing this report on another website, it was stolen and republished in violation of United States & international trademark and copyright legislation. The legal version of this report can be viewed at https://www.dailypolitical.com/2018/03/15/usana-health-sciences-inc-usna-major-shareholder-global-ltd-gull-sells-82407-shares.html.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.